Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.

MLA

Silkenstedt, Elisabeth, et al. “Notch1 Signaling in NOTCH1-Mutated Mantle Cell Lymphoma Depends on Delta-Like Ligand 4 and Is a Potential Target for Specific Antibody Therapy.” Journal of Experimental & Clinical Cancer Research : CR, vol. 38, no. 1, Nov. 2019, p. 446. EBSCOhost, https://doi.org/10.1186/s13046-019-1458-7.

APA

Silkenstedt, E., Arenas, F., Colom-Sanmartí, B., Xargay-Torrent, S., Higashi, M., Giró, A., Rodriguez, V., Fuentes, P., Aulitzky, W. E., van der Kuip, H., Beà, S., Toribio, M. L., Campo, E., López-Guerra, M., & Colomer, D. (2019). Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. Journal of Experimental & Clinical Cancer Research : CR, 38(1), 446. https://doi.org/10.1186/s13046-019-1458-7

Chicago

Silkenstedt, Elisabeth, Fabian Arenas, Berta Colom-Sanmartí, Sílvia Xargay-Torrent, Morihiro Higashi, Ariadna Giró, Vanina Rodriguez, et al. 2019. “Notch1 Signaling in NOTCH1-Mutated Mantle Cell Lymphoma Depends on Delta-Like Ligand 4 and Is a Potential Target for Specific Antibody Therapy.” Journal of Experimental & Clinical Cancer Research : CR 38 (1): 446. doi:10.1186/s13046-019-1458-7.